Powell-Braxton L, Véniant M, Latvala R D, Hirano K I, Won W B, Ross J, Dybdal N, Zlot C H, Young S G, Davidson N O
Cardiovascular Research, Genentech Inc., South San Francisco, California 94080, USA.
Nat Med. 1998 Aug;4(8):934-8. doi: 10.1038/nm0898-934.
Mutations in the low density lipoprotein (LDL) receptor gene cause familial hypercholesterolemia, a human disease characterized by premature atherosclerosis and markedly elevated plasma levels of LDL cholesterol and apolipoprotein (apo) B100. In contrast, mice deficient for the LDL receptor (Ldlr-/-) have only mildly elevated LDL cholesterol levels and little atherosclerosis. This difference results from extensive editing of the hepatic apoB mRNA in the mouse, which limits apoB100 synthesis in favor of apoB48 synthesis. We have generated Ldlr-/- mice that cannot edit the apoB mRNA and therefore synthesize exclusively apoB100. These mice had markedly elevated LDL cholesterol and apoB100 levels and developed extensive atherosclerosis on a chow diet. This authentic model of human familial hypercholesterolemia will provide a new tool for studying atherosclerosis.
低密度脂蛋白(LDL)受体基因突变会导致家族性高胆固醇血症,这是一种人类疾病,其特征为过早出现动脉粥样硬化以及血浆中LDL胆固醇和载脂蛋白(apo)B100水平显著升高。相比之下,缺乏LDL受体的小鼠(Ldlr-/-)仅具有轻度升高的LDL胆固醇水平,且几乎没有动脉粥样硬化。这种差异源于小鼠肝脏中apoB mRNA的广泛编辑,这限制了apoB100的合成,转而有利于apoB48的合成。我们已经培育出无法编辑apoB mRNA、因此仅合成apoB100的Ldlr-/-小鼠。这些小鼠的LDL胆固醇和apoB100水平显著升高,并且在普通饮食条件下就出现了广泛的动脉粥样硬化。这种人类家族性高胆固醇血症的真实模型将为研究动脉粥样硬化提供一种新工具。